The Repertoire of TP53 Mutations in Endometrioid Endometrial Cancer

被引：0
|
作者：
Weigelt, B. [1 ]
Hussein, Y. R. [1 ]
Soslow, R. A. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1285
引用
收藏
页码：311A / 311A
页数：1
相关论文
共 50 条
  • [31] TP53 Mutations and Lung Cancer: Not All Mutations Are Created Equal
    Govindan, Ramaswamy
    Weber, Jason
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (17) : 4419 - 4421
  • [32] Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
    Kyndi, M
    Alsner, J
    Hansen, LL
    Sorensen, FB
    Overgaard, J
    [J]. BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S54 - S54
  • [33] Recurrent chromosome 10 aberrations and Tp53 mutations in rat endometrial adenocarcinomas
    Nordlander, Carola
    Samuelson, Emma
    Klinga-Levan, Karin
    Behboudi, Afrouz
    [J]. HORMONAL CARCINOGENESIS V, 2008, 617 : 519 - 525
  • [34] Endometrial Serous Carcinomas Lacking TP53 Mutations: How Common Are They Really?
    Allison, Douglas
    Weigelt, Britta
    Ellenson, Lora
    [J]. MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 712 - 713
  • [35] Endometrial Serous Carcinomas Lacking TP53 Mutations: How Common Are They Really?
    Allison, Douglas
    Weigelt, Britta
    Ellenson, Lora
    [J]. LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 712 - 713
  • [36] TP53 mutations in myelodysplastic syndrome
    Misawa, S
    Horiike, S
    [J]. LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 417 - 422
  • [37] Landscape of TP53 Mutations in MPN
    Farnoud, Noushin
    Famulare, Christopher
    Papaemmanuil, Elli
    McGovern, Erin
    Medina, Juan
    Ossa, Juan E. Arango
    Rampal, Raajit K.
    Li, Bing
    Levine, Ross L.
    Mascarenhas, John
    Weinberg, Rona Singer
    Patel, Minal A.
    Hoffman, Ronald
    [J]. BLOOD, 2019, 134
  • [38] Germline mutations in the TP53 gene
    Eeles, RA
    [J]. CANCER SURVEYS, 1995, 25 : 101 - 124
  • [39] TP53 mutations in human meningiomas
    Verheijen, FM
    Sprong, M
    Kloosterman, JME
    Blaauw, G
    Thijssen, JHH
    Blankenstein, MA
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (01): : 42 - 48
  • [40] TP53 mutations sensitize to decitabine
    Peter Sidaway
    [J]. Nature Reviews Clinical Oncology, 2017, 14 : 72 - 72
12345